Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
87.40    2.10 (2.46%)
Bid:
87.00
Ask:
88.90
Spread: 1.90 (2.184%)
Market Cap: £367.39m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

Trading Update

9 Dec 2009 07:00

RNS Number : 7825D
PZ CUSSONS PLC
09 December 2009
 



9 December 2009

PZ Cussons Plc

(the "Group")

TRADING UPDATE

PZ Cussons Plc announces its trading update in respect of the half year to 30 November 2009.

First half trading

PZ Cussons is pleased to confirm that results for the first half of the financial year have been in line with management expectations, with profitability ahead of the same period last year. The financial position of the Group remains strong with cash generation during the period also in line with expectations, and with the Group remaining in a net funds position at the end of the period.

Trading

Overall performance in Europe has been strong benefiting in particular from good trading momentum in the UK and strong export sales out of Poland.

In Asia, strong performance from Australia, Indonesia and the Middle East has resulted in profitability ahead of the same period last year.

In Africa, overall profitability in Nigeria was ahead of the same period last year despite a weakening of the Nigerian naira versus the US dollar which adversely impacts results on translation to sterling. During the period there was a tightening of liquidity in the market following the strengthening of controls in the banking sector. We see this as positive in the context of the long term health of Nigeria's financial system although it has had some short term effect on sales volumes in the second quarter, particularly in the higher value electrical goods category. Personal Care and Home Care categories are now performing well as is the Nutrition business which continues to trade profitably, and volumes of electrical goods are now rising again as liquidity begins to return to the market.

 

Major Projects

Project Unity, which is the £39m investment in Nigeria's broader supply chain facilities, has continued to progress well with the new national distribution centre becoming fully operational during the period. The final phase of the project involves installation of new soap and detergent manufacturing equipment and this is on schedule for completion by August 2010.

Full year outlook

Strong performance in Europe and Asia is expected to offset any continued impact in Nigeria of adverse exchange rates and the tightening of liquidity in the market.

The outlook for the full year therefore remains positive and in line with expectations.

Directors

As recently announced, Richard Harvey will join the board on 1 January 2010 as Non Executive director and Chairman elect. Richard will take over as Chairman on 1 July 2010 when Anthony Green, Executive Chairman, retires from the board. Graham Calder, Deputy Chairman, will retire from the board on 31 March 2010.

Interim Announcement

Interim results for the half year to 30 November 2009 will be announced on Tuesday 26th January 2010. 

An analysts' presentation will be given at 9:30am on that day at the offices of Panmure Gordon, Moorgate Hall, 155 Moorgate, London EC2M 6XB.

For further information contact:

PZ Cussons Plc Tel: 0161 491 8134

Brandon Leigh - Finance Director

Hogarth Partnership Limited Tel: 020 7357 9477

John Olsen / Sarah Macleod

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUUGUAPUPBGCR
Date   Source Headline
20th May 20264:49 pmRNSDirector/PDMR Shareholding
21st Apr 20262:49 pmRNSDirector/PDMR Shareholding
14th Apr 20268:43 amRNSDirector/PDMR Shareholding
10th Apr 20264:01 pmRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSQ3 TRADING UPDATE
19th Mar 20268:59 amRNSDirector/PDMR Shareholding
3rd Mar 20264:27 pmRNSDirector/PDMR Shareholding
19th Feb 202611:04 amRNSDirector/PDMR Shareholding
13th Feb 20263:32 pmRNSDirector/PDMR Shareholding
13th Feb 20262:21 pmRNSDirector/PDMR Shareholding
11th Feb 20267:01 amRNSCapital Markets Event
11th Feb 20267:00 amRNSInterim Results
22nd Jan 20263:00 pmRNSDirectorate change
20th Jan 20264:39 pmRNSDirector/PDMR Shareholding
22nd Dec 20257:00 amRNSDirectorate change
22nd Dec 20257:00 amRNSDirectorate change
18th Dec 20255:29 pmRNSDirector/PDMR Shareholding
18th Dec 20255:29 pmRNSDirector/PDMR Shareholding
15th Dec 20254:27 pmRNSHolding(s) in Company
11th Dec 20257:00 amRNSConclusion of Strategic Review of Africa
2nd Dec 20252:42 pmRNSDirector/PDMR Shareholding
28th Nov 20253:25 pmRNSDirector/PDMR Shareholding
20th Nov 20254:23 pmRNSResult of AGM
20th Nov 20257:00 amRNSAGM Trading Statement
19th Nov 20255:57 pmRNSDirector/PDMR Shareholding
21st Oct 20255:07 pmRNSDirector/PDMR Shareholding
1st Oct 20254:20 pmRNSDirector/PDMR Shareholding
1st Oct 20254:16 pmRNSDirector/PDMR Shareholding
29th Sep 20257:00 amRNSDirectorate Change
25th Sep 202512:06 pmRNSPublication of Annual Report and Notice of AGM
24th Sep 20253:56 pmRNSDirector/PDMR Shareholding
19th Sep 20255:03 pmRNSDirector/PDMR Shareholding
17th Sep 20257:00 amRNSFinal Results
20th Aug 20259:16 amRNSDirector/PDMR Shareholding
21st Jul 20255:07 pmRNSDirector/PDMR Shareholding
26th Jun 20257:00 amRNSUpdate on St. Tropez
19th Jun 20254:47 pmRNSDirector/PDMR Shareholding
18th Jun 20257:00 amRNSSale of Joint Venture and Trading Update
21st May 20254:49 pmRNSDirector/PDMR Shareholding
7th May 20253:29 pmRNSDirector Declaration
23rd Apr 20254:32 pmRNSDirector/PDMR Shareholding
10th Apr 20255:06 pmRNSDirector/PDMR Shareholding
19th Mar 20254:37 pmRNSDirector/PDMR Shareholding
19th Feb 202511:38 amRNSDirector/PDMR Shareholding
11th Feb 20257:00 amRNSInterim Results
21st Jan 202511:43 amRNSDirector/PDMR Shareholding
19th Dec 20244:24 pmRNSDirector/PDMR Shareholding
6th Dec 20243:42 pmRNSDirector/PDMR Shareholding
21st Nov 20245:03 pmRNSResult of AGM
21st Nov 20247:00 amRNSAGM Trading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.